Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
Baxter
Harvard Business School
AstraZeneca
Covington
Medtronic
Julphar
QuintilesIMS

Generated: May 22, 2018

DrugPatentWatch Database Preview

NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Naloxone Hydrochloride And Pentazocine Hydrochloride, and when can generic versions of Naloxone Hydrochloride And Pentazocine Hydrochloride launch?

Naloxone Hydrochloride And Pentazocine Hydrochloride is a drug marketed by Gavis Pharms, Sun Pharm Inds Ltd, and Watson Labs. and is included in three NDAs.

The generic ingredient in NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE is naloxone hydrochloride; pentazocine hydrochloride. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride; pentazocine hydrochloride profile page.
Summary for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
Drug patent expirations by year for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE
Pharmacology for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

US Patents and Regulatory Information for NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gavis Pharms NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075735-001 Jul 11, 2001 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075523-001 Mar 17, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 074736-001 Jan 21, 1997 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Farmers Insurance
McKesson
US Department of Justice
Chubb
Johnson and Johnson
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.